LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Y39983 | 10 | uM | LJP6 | 1 | P01 | 72 | hr | 1334 | 2483 | 3955 | 0.6277 | 0.4859 |
BT-20 | Y39983 | 10 | uM | LJP6 | 2 | P01 | 72 | hr | 1334 | 2579 | 3899 | 0.6614 | 0.5310 |
BT-20 | Y39983 | 10 | uM | LJP6 | 3 | P01 | 72 | hr | 1334 | 2368 | 3921 | 0.6039 | 0.4459 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 1 | H06 | 72 | hr | 1334 | 4248 | 3955 | 1.0739 | 1.0930 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 2 | H06 | 72 | hr | 1334 | 4102 | 3899 | 1.0520 | 1.0667 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 3 | H06 | 72 | hr | 1334 | 3793 | 3921 | 0.9673 | 0.9577 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 1 | H05 | 72 | hr | 1334 | 4161 | 3955 | 1.0519 | 1.0656 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 2 | H05 | 72 | hr | 1334 | 4165 | 3899 | 1.0682 | 1.0871 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 3 | H05 | 72 | hr | 1334 | 3798 | 3921 | 0.9685 | 0.9593 |
BT-20 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1334 | 3542 | 3955 | 0.8954 | 0.8639 |
BT-20 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1334 | 3848 | 3899 | 0.9869 | 0.9830 |
BT-20 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1334 | 3162 | 3921 | 0.8064 | 0.7415 |
BT-20 | Nintedanib | 1.11 | uM | LJP6 | 1 | H03 | 72 | hr | 1334 | 3920 | 3955 | 0.9910 | 0.9884 |
BT-20 | Nintedanib | 1.11 | uM | LJP6 | 2 | H03 | 72 | hr | 1334 | 3687 | 3899 | 0.9456 | 0.9290 |
BT-20 | Nintedanib | 1.11 | uM | LJP6 | 3 | H03 | 72 | hr | 1334 | 3399 | 3921 | 0.8668 | 0.8243 |
BT-20 | Nintedanib | 3.33 | uM | LJP6 | 1 | H02 | 72 | hr | 1334 | 2776 | 3955 | 0.7018 | 0.5955 |
BT-20 | Nintedanib | 3.33 | uM | LJP6 | 2 | H02 | 72 | hr | 1334 | 2962 | 3899 | 0.7597 | 0.6743 |
BT-20 | Nintedanib | 3.33 | uM | LJP6 | 3 | H02 | 72 | hr | 1334 | 2945 | 3921 | 0.7510 | 0.6636 |
BT-20 | Nintedanib | 10 | uM | LJP6 | 1 | H01 | 72 | hr | 1334 | 3042 | 3955 | 0.7690 | 0.6914 |
BT-20 | Nintedanib | 10 | uM | LJP6 | 2 | H01 | 72 | hr | 1334 | 2805 | 3899 | 0.7194 | 0.6164 |
BT-20 | Nintedanib | 10 | uM | LJP6 | 3 | H01 | 72 | hr | 1334 | 2693 | 3921 | 0.6868 | 0.5706 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 1334 | 3769 | 3930 | 0.9588 | 0.9468 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 2 | H12 | 72 | hr | 1334 | 3928 | 4051 | 0.9696 | 0.9619 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 3 | H12 | 72 | hr | 1334 | 4154 | 4117 | 1.0088 | 1.0108 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1334 | 3036 | 3930 | 0.7724 | 0.6945 |